abs196.txt	radical	surgery	still	represents	the	treatment	choice	for	several	malignancies	however		local	and	distant	tumor	relapses	remain	the	major	causes	of	treatmentfailure		indicating	that	a	postsurgery	consolidation	treatment	is	necessary	immunotherapy	with	checkpoint	inhibitors	has	elicited	impressive	clinicalresponses	in	several	types	of	human	malignancies	and	may	represent	the	idealconsolidation	treatment	after	surgery		here		we	genetically	engineered	plateletsfrom	megakaryocyte	(mk)	progenitor	cells	to	express	the	programmed	cell	deathprotein	1	(pd-1)		the	pd-1	platelet	and	its	derived	microparticle	couldaccumulate	within	the	tumor	surgical	wound	and	revert	exhausted	cd8+	t	cells	leading	to	the	eradication	of	residual	tumor	cells		furthermore		when	a	low	doseof	cyclophosphamide	(cp)	was	loaded	into	pd-1-expressing	platelets	todeplete	regulatory	t	cells	(tregs)		an	increased	frequency	of	reinvigorated	cd8+lymphocyte	cells	was	observed	within	the	postsurgery	tumor	microenvironment	directly	preventing	tumor	relapse	
